SYMPOSIUM CHAIRS

This powerful and engaging four-day event in downtown Chicago is chaired by:

Symposium Chair
William J. Gradishar, MD

Symposium Co-Chair
V. Craig Jordan
OBE, PhD, DSc

Symposium Co-Chair
Monica Morrow, MD

 

2014 LYNN SAGE DISTINGUISHED LECTURER

Stuart J. Schnitt, MD

Stuart J. Schnitt, MD

The Continuing Dilemma of Ductal Carcinoma in Situ

 

CONNIE MOSKOW MEMORIAL DEBATE

All Women with Triple Negative Breast Cancer Should Receive Neoadjuvant Therapy

Pro:
Eric Winer, MD
Con:
Anthony Elias, MD

 

2014 Lurie Cancer Center
Lynn Sage Breast Cancer Symposium,
Thursday, October 9 - Sunday, October 12
at The Fairmont Chicago.

The optimal management of breast cancer has rapidly evolved. A multidisciplinary team of medical, surgical and radiation oncologists along with pathologists, plastic surgeons, genetics counselors and radiologists are routinely involved in treatment planning for individuals diagnosed with breast cancer. In addition, with the emergence of prevention and early detection strategies, women at high risk of developing breast cancer are now evaluated for medical therapies, surgical options and lifestyle changes that may reduce their risk of developing breast cancer.

The 16th Annual Lynn Sage Breast Cancer Symposium provides formal presentations as well as ample opportunity for interdisciplinary audience response case discussions. The Symposium is geared toward practitioners treating breast cancer patients. Informal interaction with national and international thought leaders is frequently cited as one of the highlights of the Symposium.

Online pre-registration for 2014 is now open!

Educational Objectives

At the conclusion of this symposium participants should be able to:

  1. Incorporate current guidelines and recent data on local therapies, including advances in surgical and radiation therapy, into the treatment of patients with breast cancer.
  2. Integrate biomarkers, molecular assays, and other risk assessment tools in treatment decision-making for breast cancer when appropriate.
  3. Review current standards and emerging data regarding systemic therapies for the treatment of early-stage, locally advanced, and metastatic breast cancer.
  4. Summarize the challenges and available options in treating triple negative breast cancer.
  5. Identify new agents for overcoming endocrine resistance.
  6. Identify the options for individualizing care in the breast cancer patient and the challenges associated with providing care and long term survivorship planning.
  7. Recognize the unique clinical and surgical decisions which need to be taken into consideration in younger and elderly patients diagnosed with breast cancer.

 

Feinberg school of Medicine NCI

Register

INTERNATIONAL PHYSICIANS

FUTURE SYMPOSIUM

Future symposia dates
in Chicago:


October 29-
November 1, 2015

September 22-25, 2016

 

TWITTER

Use #LSBC14 to follow and share updates from the Symposium.

 

Symposium Chairs

This powerful and engaging four-day event in downtown Chicago is chaired by:

Symposium Chair
William J. Gradishar, MD

Symposium Co-Chair
V. Craig Jordan
OBE, PhD, DSc

Symposium Co-Chair
Monica Morrow, MD

 

2014 Distinguished Lecturer

Stuart J. Schnitt, MD

Stuart J. Schnitt, MD

 

Connie Mosckow Memorial Debate

All Women with TNBC Should Receive Neoadjuvant Therapy

Pro:
Eric Winer, MD
Con:
Anthony Elias, MD

 

Future Dates

October 29-November 1, 2015

September 22-25, 2016

 

Other Links

Join Our Mailing List

Sister Cities Medical Initiative (for International Physicians)

Breast Cancer Achievement Awards (for Fellows and Residents)

Clinical Trials


Use the hashtag #LSBC14 to follow and share updates from the 2014 Lynn Sage Breast Cancer Symposium

© Robert H. Lurie Comprehensive Cancer Center of Northwestern University